Gene · 3660
Papers2,395
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,395
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell analysis reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of ovarian cancer. | Commun Biol | 2024 | 38182756 | PubTator, text mining | PubMed |
| The single-cell transcriptomic atlas and RORA-mediated 3D epigenomic remodeling in driving corneal epithelial differentiation. | Nat Commun | 2024 | 38177186 | PubTator, text mining | PubMed |
| Early Atf4 activity drives airway club and goblet cell differentiation. | Life Sci Alliance | 2024 | 38176727 | PubTator, text mining | PubMed |
| Lymphatic vessel: origin, heterogeneity, biological functions, and therapeutic targets. | Signal Transduct Target Ther | 2024 | 38172098 | PubTator, text mining | PubMed |
| The chemokine receptor CXCR3 promotes CD8+ T cell-dependent lung pathology during influenza pathogenesis. | Sci Adv | 2024 | 38170765 | PubTator, text mining | PubMed |
| Identification of a PANoptosis-related Gene Signature for Predicting the Prognosis, Tumor Microenvironment and Therapy Response in Breast Cancer. | J Cancer | 2024 | 38169571 | PubTator, text mining | PubMed |
| microRNA-622 upregulates cell cycle process by targeting FOLR2 to promote CRC proliferation. | BMC Cancer | 2024 | 38166756 | PubTator, text mining | PubMed |
| The predictive efficacy of programmed cell death in immunotherapy of melanoma: A comprehensive analysis of gene expression data for programmed cell death biomarker and therapeutic target discovery. | Environ Toxicol | 2024 | 38140739 | PubTator, text mining | PubMed |
| Prognostic, immunity, stemness, and anticancer drug sensitivity characterization of pyroptosis related genes in non-small cell lung cancer. | Thorac Cancer | 2024 | 38115677 | PubTator, text mining | PubMed |
| Opposing roles by KRAS and BRAF mutation on immune cell infiltration in colorectal cancer - possible implications for immunotherapy. | Br J Cancer | 2024 | 38040818 | PubTator, text mining | PubMed |
| Single-Cell Atlas of Human Ovaries Reveals The Role Of The Pyroptotic Macrophage in Ovarian Aging. | Adv Sci (Weinh) | 2024 | 38036420 | PubTator, text mining | PubMed |
| Global Transcriptome Analysis Reveals Distinct Phases of the Endothelial Response to TNF. | J Immunol | 2024 | 38019121 | PubTator, text mining | PubMed |
| ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma. | Blood Cancer Discov | 2024 | 37934799 | PubTator, text mining | PubMed |
| Apolipoprotein L genes are novel mediators of inflammation in beta cells. | Diabetologia | 2024 | 37924378 | PubTator, text mining | PubMed |
| Expression of programmed death-ligand 1, IRF1 and CD8 T lymphocyte infiltration in a primary subset of breast cancer patients in Sudan. | J Taibah Univ Med Sci | 2024 | 37876597 | PubTator, text mining | PubMed |
| A single-nucleus transcriptomic atlas of primate liver aging uncovers the pro-senescence role of SREBP2 in hepatocytes. | Protein Cell | 2024 | 37378670 | PubTator, text mining | PubMed |
| Deciphering treatment resistance in metastatic colorectal cancer: roles of drug transports, EGFR mutations, and HGF/c-MET signaling. | Front Pharmacol | 2023 | 38269272 | PubTator, text mining | PubMed |
| The potential applications of artificially modified exosomes derived from mesenchymal stem cells in tumor therapy. | Front Oncol | 2023 | 38250549 | PubTator, text mining | PubMed |
| Non-Coding RNAs as Key Regulators in Lung Cancer. | Int J Mol Sci | 2023 | 38203731 | PubTator, text mining | PubMed |
| The current status and future of PD-L1 in liver cancer. | Front Immunol | 2023 | 38155974 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3660/papers?page=6